Copyright Reports & Markets. All rights reserved.

Global Joint Pain Injections Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global Joint Pain Injections Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Joint Pain Injections Market Size 2014-2024
        • 2.1.2 Joint Pain Injections Market Size CAGR by Region
      • 2.2 Joint Pain Injections Segment by Type
        • 2.2.1 Corticosteroid Injections
        • 2.2.2 Hyaluronic Acid Injections
      • 2.3 Joint Pain Injections Market Size by Type
        • 2.3.1 Global Joint Pain Injections Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Joint Pain Injections Market Size Growth Rate by Type (2014-2019)
      • 2.4 Joint Pain Injections Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Retail Pharmacies
        • 2.4.3 Online Pharmacies
      • 2.5 Joint Pain Injections Market Size by Application
        • 2.5.1 Global Joint Pain Injections Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Joint Pain Injections Market Size Growth Rate by Application (2014-2019)

      3 Global Joint Pain Injections by Players

      • 3.1 Global Joint Pain Injections Market Size Market Share by Players
        • 3.1.1 Global Joint Pain Injections Market Size by Players (2017-2019)
        • 3.1.2 Global Joint Pain Injections Market Size Market Share by Players (2017-2019)
      • 3.2 Global Joint Pain Injections Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Joint Pain Injections by Regions

      • 4.1 Joint Pain Injections Market Size by Regions
      • 4.2 Americas Joint Pain Injections Market Size Growth
      • 4.3 APAC Joint Pain Injections Market Size Growth
      • 4.4 Europe Joint Pain Injections Market Size Growth
      • 4.5 Middle East & Africa Joint Pain Injections Market Size Growth

      5 Americas

      • 5.1 Americas Joint Pain Injections Market Size by Countries
      • 5.2 Americas Joint Pain Injections Market Size by Type
      • 5.3 Americas Joint Pain Injections Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Joint Pain Injections Market Size by Countries
      • 6.2 APAC Joint Pain Injections Market Size by Type
      • 6.3 APAC Joint Pain Injections Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Joint Pain Injections by Countries
      • 7.2 Europe Joint Pain Injections Market Size by Type
      • 7.3 Europe Joint Pain Injections Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Joint Pain Injections by Countries
      • 8.2 Middle East & Africa Joint Pain Injections Market Size by Type
      • 8.3 Middle East & Africa Joint Pain Injections Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Joint Pain Injections Market Forecast

      • 10.1 Global Joint Pain Injections Market Size Forecast (2019-2024)
      • 10.2 Global Joint Pain Injections Forecast by Regions
        • 10.2.1 Global Joint Pain Injections Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Joint Pain Injections Forecast by Type
      • 10.8 Global Joint Pain Injections Forecast by Application

      11 Key Players Analysis

      • 11.1 Pfizer
        • 11.1.1 Company Details
        • 11.1.2 Joint Pain Injections Product Offered
        • 11.1.3 Pfizer Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Pfizer News
      • 11.2 Sanofi
        • 11.2.1 Company Details
        • 11.2.2 Joint Pain Injections Product Offered
        • 11.2.3 Sanofi Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Sanofi News
      • 11.3 Anika Therapeutics
        • 11.3.1 Company Details
        • 11.3.2 Joint Pain Injections Product Offered
        • 11.3.3 Anika Therapeutics Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Anika Therapeutics News
      • 11.4 Zimmer Biomet
        • 11.4.1 Company Details
        • 11.4.2 Joint Pain Injections Product Offered
        • 11.4.3 Zimmer Biomet Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Zimmer Biomet News
      • 11.5 Ferring Pharmaceuticals
        • 11.5.1 Company Details
        • 11.5.2 Joint Pain Injections Product Offered
        • 11.5.3 Ferring Pharmaceuticals Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Ferring Pharmaceuticals News
      • 11.6 Bioventus
        • 11.6.1 Company Details
        • 11.6.2 Joint Pain Injections Product Offered
        • 11.6.3 Bioventus Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Bioventus News
      • 11.7 Flexion Therapeutics
        • 11.7.1 Company Details
        • 11.7.2 Joint Pain Injections Product Offered
        • 11.7.3 Flexion Therapeutics Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Flexion Therapeutics News
      • 11.8 Seikagaku
        • 11.8.1 Company Details
        • 11.8.2 Joint Pain Injections Product Offered
        • 11.8.3 Seikagaku Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Seikagaku News
      • 11.9 Chugai Pharmaceutical
        • 11.9.1 Company Details
        • 11.9.2 Joint Pain Injections Product Offered
        • 11.9.3 Chugai Pharmaceutical Joint Pain Injections Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Chugai Pharmaceutical News

      12 Research Findings and Conclusion

      In medicine, a joint injection (intra-articular injection) is a procedure used in the treatment of inflammatory joint conditions, such as rheumatoid arthritis, psoriatic arthritis, gout, tendinitis, bursitis, Carpal Tunnel Syndrome, and occasionally osteoarthritis. A hypodermic needle is injected into the affected joint where it delivers a dose of any one of many anti-inflammatory agents, the most common of which are corticosteroids. Hyaluronic acid, because of its high viscosity, is sometimes used to replace bursa fluids. The technique may be used to also withdraw excess fluid from the joint.

      According to this study, over the next five years the Joint Pain Injections market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Joint Pain Injections business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Joint Pain Injections market by product type, application, key companies and key regions.

      This study considers the Joint Pain Injections value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Corticosteroid Injections
      Hyaluronic Acid Injections
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Pfizer
      Sanofi
      Anika Therapeutics
      Zimmer Biomet
      Ferring Pharmaceuticals
      Bioventus
      Flexion Therapeutics
      Seikagaku
      Chugai Pharmaceutical

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Joint Pain Injections market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Joint Pain Injections market by identifying its various subsegments.
      Focuses on the key global Joint Pain Injections players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Joint Pain Injections with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Joint Pain Injections submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now